Table 1.
The characteristics of cases and controls.
| Characteristics | Case (n = 89) | Control (n = 103) | P value* |
|---|---|---|---|
| Age (yrs) | 51.84 ± 14.09 | 50.01 ± 12.09 | 0.393b |
| ALT (U/L) | 26.00 (19.00, 42.50) | 21.00 (17.00, 26.00) | <0.001 a |
| AST (U/L) | 24.00 (18.50, 31.00) | 22.00 (18.00, 27.00) | 0.093a |
| CRE (mmol/L) | 80.52 ± 16.66 | 77.77 ± 9.79 | 0.159b |
| UA (mmol/L) | 423.46 ± 147.48 | 344.20 ± 67.06 | <0.001 b |
| Glu (mmol/L) | 5.30 (4.83, 6.00) | 4.96 (4.72, 5.25) | <0.001 a |
| Cholesterol (mmol/L) | 4.94 ± 1.17 | 4.42 ± 0.68 | <0.001 b |
| HDL (mmol/L) | 1.23 ± 0.31 | 1.50 ± 0.35 | <0.001 b |
| LDL (mmol/L) | 2.51 ± 0.98 | 2.60 ± 0.52 | 0.427b |
| TG (mmol/L) | 2.52 ± 1.52 | 1.17 ± 0.47 | <0.001 b |
| WBC (×109/L) | 8.97 ± 3.48 | 6.42 ± 1.56 | <0.001 b |
*The value in bold indicates statistical significance.
aNot conform to normal distribution, nonparametric rank test was applied, and the results were described as median (interquartile range). bConform to normal distribution, two-sample t-test was applied, and the variables were described as mean ± SD.
ALT: glutamic pyruvic transaminase; AST: glutamic oxalacetic transaminase; CRE: creatinine; UA: uric acid; Glu: blood glucose; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglyceride; WBC: white blood cell.